Panacea Biotec Limited — Important, 05-02-2026: Updates
05-02-2026 | 03:15 pm
05-02-2026 | 03:15 pm
Panacea Biotec's Baddi facility received a non-compliance statement for Good Manufacturing Practice (GMP) from Hungary's NCPHP, leading to revocation of GMP certificates. This impacts supplies of non-vital products to the EU. EU revenue is 0.32% of total consolidated net revenues. The company is implementing corrective actions.
No comments yet. Be the first to comment!
